The global HIV response has made tremendous progress but is entering a new phase with
additional challenges. Scientific innovations have led to multiple safe, effective, and durable …

Objectives As countries have scaled up access to antiretroviral therapy (ART) for HIV,
attrition rates of up to 30% annually have created a large pool of individuals who initiate …

Background Universal testing and treatment (UTT) for all people living with HIV has only
been assessed under experimental conditions in cluster-randomised trials. The public …

Introduction Long‐acting and extended delivery (LAED) regimens for HIV treatment and
prevention offer unique benefits to expand uptake, effective use and adherence. To date …

Background There is limited study of persons deemed “harder to reach” by HIV treatment
services, including those discontinuing or never initiating antiretroviral therapy (ART). We …

Background Recipients of health services value not only convenience but also respectful,
kind, and helpful providers. To date, research to improve person-centred HIV treatment has …

Introduction Poor client− provider communication is a critical barrier to long‐term retention in
care among people living with HIV. However, standardized assessments of this key metric …

Objectives To compare unannounced standardised patient approach (eg, mystery clients)
with typical exit interviews for assessing patient experiences in HIV care (eg, unfriendly …

Abstract The Integrated Change Model describes several social and cognitive factors (eg,
health attitudes, social support, self-efficacy) that can affect medication adherence. Guided …

Background The introduction of universal test and treat (UTT) strategy has demonstrated a
reduction in attrition in some low‐resource settings. UTT was introduced in Ethiopia in 2016 …